Weinhoff Gregory M — SEC Form 4 Insider Trading Activity

Summary

Updated Jul 16, 2026

Weinhoff Gregory M has filed 1 SEC Form 4 filing across 1 company in the last 90 days — selling. Lifetime open-market sales: $3.33M.

Profile

Weinhoff Gregory M

Gregory M. Weinhoff is the Chief Business Officer at Centessa Pharmaceuticals plc, a clinical-stage pharmaceutical company focused on developing innovative therapies. He has been involved in multiple SEC filings related to his role at the company.

RoleChief Business Officer
Notability30/100

Board memberships

Awards & honors

Recent Transactions

DateTickerCompanyCodeSharesPriceValue
2026-06-24CNTACentessa Pharmaceuticals plcD — Derivative transaction65.9K—
2026-03-27CNTACentessa Pharmaceuticals plcS — Open-market sale [10b5-1]24.0K$30.00$720K
2026-03-27CNTACentessa Pharmaceuticals plcM — Option exercise [10b5-1]24.0K$3.85$92K
2026-03-13CNTACentessa Pharmaceuticals plcS — Open-market sale [10b5-1]11.9K$27.16$324K
2026-03-13CNTACentessa Pharmaceuticals plcS — Open-market sale [10b5-1]61.3K$26.17$1.60M
2026-02-03CNTACentessa Pharmaceuticals plcA — Grant or award31.0K$0.00
2026-02-03CNTACentessa Pharmaceuticals plcF — Tax withholding / forfeiture14.2K$24.57$348K
2025-07-25CNTACentessa Pharmaceuticals plcS — Open-market sale10.0K$15.56$156K
2025-07-25CNTACentessa Pharmaceuticals plcM — Option exercise10.0K$3.85$38K
2024-12-31CNTACentessa Pharmaceuticals plcF — Tax withholding / forfeiture11.7K$16.35$192K
2024-12-26CNTACentessa Pharmaceuticals plcS — Open-market sale [10b5-1]10.0K$17.04$170K
2024-12-26CNTACentessa Pharmaceuticals plcM — Option exercise [10b5-1]10.0K$3.85$38K
2024-11-27CNTACentessa Pharmaceuticals plcS — Open-market sale [10b5-1]10.0K$17.66$177K
2024-11-27CNTACentessa Pharmaceuticals plcM — Option exercise [10b5-1]10.0K$3.85$38K
2024-10-25CNTACentessa Pharmaceuticals plcS — Open-market sale [10b5-1]11.7K$15.38$181K
2024-10-02CNTACentessa Pharmaceuticals plcF — Tax withholding / forfeiture11.7K$15.79$185K

Companies — Last 90 Days

Frequently Asked Questions

Who is Weinhoff Gregory M?

Gregory M. Weinhoff is the Chief Business Officer at Centessa Pharmaceuticals plc, a clinical-stage pharmaceutical company focused on developing innovative therapies. He has been involved in multiple SEC filings related to his role at the company.…

How many SEC Form 4 filings has Weinhoff Gregory M submitted recently?

1 primary Form 4 filings in the last 90 days, covering 1 company.

Has Weinhoff Gregory M been buying or selling stock?

Recorded transactions: 0 open-market purchases () and 7 open-market sales ($3.33M) across all tracked filings.

Where can I see all of Weinhoff Gregory M's SEC filings?

All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.

Learn More

Open the live Weinhoff Gregory M profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.